Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

203645 BMP-7, Human, Recombinant, E. coli

203645
  
Purchase on Sigma-Aldrich

Overview

Replacement Information

Key Spec Table

Purity
≥95% by SDS-PAGE
Description
Overview

This product has been discontinued.





Recombinant, human bone morphogenetic protein-7 (BMP-7) expressed in E. coli and purified by proprietary chromatographic methods. BMP-7 is a monomeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-7 plays an important role in embryogenic renal and eye development.
Catalogue Number203645
Brand Family Calbiochem®
SynonymsBone morphogenetic protein 7 precursor, Osteogenic protein 1, OP-1, Eptotermin α
References
ReferencesFabeck, L., et al. 2006. J. Bone Joint Surg. Br. 88, 116.
Leung-Hagesteijn, C., et al. 2005. Mol. Cell Biol. 25, 3648.
Makino, T., et al. 2005. J. Orthop. Res. 23, 632.
Niksic, L. and Martin, P.Y. 2005. Rev. Med. Suisse 1, 568.
Yang, S., et al. 2005. Cancer Res. 65, 5769.
Kontaxis, A., et al. 2004. Proc. Inst. Mech. Eng. 218, 381.
Product Information
FormLyophilized
FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
Applications
Biological Information
Purity≥95% by SDS-PAGE
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage -20°C
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications

Documentation

BMP-7, Human, Recombinant, E. coli Certificates of Analysis

TitleLot Number
203645

References

Reference overview
Fabeck, L., et al. 2006. J. Bone Joint Surg. Br. 88, 116.
Leung-Hagesteijn, C., et al. 2005. Mol. Cell Biol. 25, 3648.
Makino, T., et al. 2005. J. Orthop. Res. 23, 632.
Niksic, L. and Martin, P.Y. 2005. Rev. Med. Suisse 1, 568.
Yang, S., et al. 2005. Cancer Res. 65, 5769.
Kontaxis, A., et al. 2004. Proc. Inst. Mech. Eng. 218, 381.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision20-May-2008 RFH
SynonymsBone morphogenetic protein 7 precursor, Osteogenic protein 1, OP-1, Eptotermin α
DescriptionRecombinant, human bone morphogenetic protein-7 (BMP-7) expressed in E. coli and purified by proprietary chromatographic methods. BMP-7 is a monomeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-7 plays an important role in embryogenic renal and eye development.
FormLyophilized
FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
Purity≥95% by SDS-PAGE
SolubilityReconstitute to ≥100 µg/ml in H₂O containing 0.1% BSA or HSA. Further dilute with aqueous buffers just prior to use.
Storage -20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Toxicity Standard Handling
ReferencesFabeck, L., et al. 2006. J. Bone Joint Surg. Br. 88, 116.
Leung-Hagesteijn, C., et al. 2005. Mol. Cell Biol. 25, 3648.
Makino, T., et al. 2005. J. Orthop. Res. 23, 632.
Niksic, L. and Martin, P.Y. 2005. Rev. Med. Suisse 1, 568.
Yang, S., et al. 2005. Cancer Res. 65, 5769.
Kontaxis, A., et al. 2004. Proc. Inst. Mech. Eng. 218, 381.